BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu J, Xie ZY, Zhu DH, Li LJ. Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature. World J Clin Cases 2021; 9(7): 1705-1713 [PMID: 33728315 DOI: 10.12998/wjcc.v9.i7.1705]
URL: https://www.wjgnet.com/2307-8960/full/v9/i7/1705.htm
Number Citing Articles
1
Gabriele Zanirati, Laura Provenzi, Lucas Lobraico Libermann, Sabrina Comin Bizotto, Isadora Machado Ghilardi, Daniel Rodrigo Marinowic, Ashok K. Shetty, Jaderson Costa Da Costa. Stem cell-based therapy for COVID-19 and ARDS: a systematic reviewnpj Regenerative Medicine 2021; 6(1) doi: 10.1038/s41536-021-00181-9
2
Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec. Mesenchymal Stromal Cells: Potential Option for COVID-19 TreatmentPharmaceutics 2021; 13(9): 1481 doi: 10.3390/pharmaceutics13091481